Thymoma Type B3 research hub

Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)

This study is looking into a new treatment called nivolumab for people with certain types of thymus gland cancer (Type B3 Thymoma or Thymic Carcinoma) that has come back or spread, and has already been treated with chemotherapy.